全文获取类型
收费全文 | 6276篇 |
免费 | 486篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 250篇 |
妇产科学 | 172篇 |
基础医学 | 892篇 |
口腔科学 | 149篇 |
临床医学 | 662篇 |
内科学 | 1287篇 |
皮肤病学 | 90篇 |
神经病学 | 648篇 |
特种医学 | 105篇 |
外国民族医学 | 4篇 |
外科学 | 625篇 |
综合类 | 39篇 |
一般理论 | 2篇 |
预防医学 | 732篇 |
眼科学 | 98篇 |
药学 | 421篇 |
中国医学 | 5篇 |
肿瘤学 | 565篇 |
出版年
2023年 | 73篇 |
2022年 | 93篇 |
2021年 | 221篇 |
2020年 | 171篇 |
2019年 | 195篇 |
2018年 | 201篇 |
2017年 | 184篇 |
2016年 | 175篇 |
2015年 | 208篇 |
2014年 | 255篇 |
2013年 | 363篇 |
2012年 | 470篇 |
2011年 | 527篇 |
2010年 | 257篇 |
2009年 | 242篇 |
2008年 | 421篇 |
2007年 | 431篇 |
2006年 | 387篇 |
2005年 | 382篇 |
2004年 | 313篇 |
2003年 | 275篇 |
2002年 | 285篇 |
2001年 | 53篇 |
2000年 | 53篇 |
1999年 | 49篇 |
1998年 | 46篇 |
1997年 | 37篇 |
1996年 | 33篇 |
1995年 | 23篇 |
1994年 | 25篇 |
1993年 | 12篇 |
1992年 | 27篇 |
1991年 | 21篇 |
1990年 | 22篇 |
1989年 | 12篇 |
1988年 | 15篇 |
1987年 | 27篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 9篇 |
1974年 | 11篇 |
1973年 | 8篇 |
1972年 | 8篇 |
1970年 | 10篇 |
1968年 | 8篇 |
排序方式: 共有6776条查询结果,搜索用时 31 毫秒
1.
2.
Anne-Sophie Worm Fenger Markus Harboe Olsen Maria Louise Fabritius Christian Gunge Riberholt Kirsten Møller 《Acta anaesthesiologica Scandinavica》2023,67(2):240-247
Background
Hyperglycaemia is common in patients with acute brain injury admitted to an intensive care unit (ICU). Many studies have found associations between development of hyperglycaemia and increased mortality in hospitalised patients. However, the optimal target for blood glucose control is unknown. We want to conduct a systematic review with meta-analysis and trial sequential analysis to explore the beneficial and harmful effects of restrictive versus liberal glucose control on patient outcomes in adults with severe acute brain injury.Methods
We will systematically search medical databases including CENTRAL, Embase, MEDLINE and trial registries. We will search the following websites for ongoing or unpublished trials: http://www.controlled-trials.com/ , http://www.clinicaltrials.gov/ , www.eudraCT.com , http://centerwatch.com/ , The Cochrane Library's CENTRAL, PubMed, EMBASE, Science Citation Index Expanded and CINAHL. Two authors will independently review and select trials and extract data. We will include randomised trials comparing levels of glucose control in our analyses and observational studies will be included to address potential harms. The primary outcomes are defined as all-cause mortality, functional outcome and health-related quality of life. Secondary outcomes include serious adverse events including hypoglycaemia, length of ICU stay and duration of mechanical ventilation, and explorative outcomes including intracranial pressure and infection. Trial Sequential Analysis will be used to investigate the risk of type I error due to repetitive testing and to further explore imprecision. Quality of trials will be evaluated using the Cochrane Risk of Bias tool, and quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.Discussion
The results of the systematic review will be disseminated through peer-reviewed publication. With the review, we hope to inform future randomised clinical trials and improve clinical practice. 相似文献3.
4.
5.
6.
J.P. Brouillet B. Hanslick T. Maudelonde M.T. Pivat J. Grenier F. Blanc H. Rochefort 《Clinical biochemistry》1991,24(6):491-496
Using a sandwich enzyme-linked immunoassay, plasma total cathepsin D concentration was assayed in 40 breast cancer patients and 84 patients with various liver diseases and compared to that of 52 normal subjects. There were no significant variations found in breast cancer patients related to tumor size, node invasiveness or metastases. In normal women, cathepsin D levels were slightly but not significantly increased in the luteal phase and in pregnancy. By contrast, plasma cathepsin D concentration was significantly increased in 70-75% of patients with liver disease (cirrhosis, hepatocarcinoma, hepatitis), but not in those with liver steatosis. Cathepsin D was independent of most of the plasma hepatic function tests and was correlated with alpha-fetoprotein in cirrhosis and with alpha-fucosidase in primary hepatocellular carcinoma. We conclude that plasma cathepsin D is not a useful marker in breast cancer. However, since the cellular level of this protease is associated with risk of metastasis in breast cancer, clinical follow-up will be required to test whether high cathepsin D plasma concentration has any prognostic value in liver cirrhosis and primary hepatocarcinoma. 相似文献
7.
8.
9.
10.